Liu Wang, Li Jean C, Huang Jian, Chen Jiepeng, Holzbeierlein Jeffrey, Li Benyi
Department of Urology, The University of Kansas Medical Center, Kansas City, KS, United States.
Institute of Molecular Pathology, The Affiliated Hospital, Guangdong Medical University, Zhanjiang, China.
Front Oncol. 2020 Nov 3;10:568110. doi: 10.3389/fonc.2020.568110. eCollection 2020.
Alternol and its oxidate isomer Alteronol are small compounds isolated from the fermentation of a mutant fungus obtained from bark. Preclinical studies showed their potent anti-cancer activities, including attenuating cellular survival pathways, altering protein levels of cell cycle regulators, activating xanthine dehydrogenase to cause accumulation of cellular reactive oxygen species and disrupting cell metabolism by disturbing four Krebs cycle enzymes specifically in malignant cells while having no significant effect on benign cells. In cancer cell culture models, Alternol or Alteronol exert their anti-cancer effect by inducing cell cycle arrest and triggering apoptotic cell death. In mice xenograft models, Alternol or Alteronol potently suppresses tumor growth with no obvious toxicity to the host with a wide therapeutic index over 30-fold. In conclusion, Alternol or Alteronol possess a great potential and feasibility to be developed as an effective anti-tumor therapeutic.
间苯三酚及其氧化异构体变间苯三酚是从树皮中提取的一种突变真菌发酵产物中分离出的小分子化合物。临床前研究表明它们具有强大的抗癌活性,包括减弱细胞存活途径、改变细胞周期调节蛋白水平、激活黄嘌呤脱氢酶导致细胞活性氧积累,以及通过特异性干扰恶性细胞中的四种三羧酸循环酶来破坏细胞代谢,而对良性细胞无显著影响。在癌细胞培养模型中,间苯三酚或变间苯三酚通过诱导细胞周期停滞和触发凋亡性细胞死亡发挥抗癌作用。在小鼠异种移植模型中,间苯三酚或变间苯三酚能有效抑制肿瘤生长,对宿主无明显毒性,治疗指数高达30倍以上。总之,间苯三酚或变间苯三酚具有作为有效抗肿瘤治疗药物开发的巨大潜力和可行性。